Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
Provided By GlobeNewswire
Last update: Apr 17, 2025
Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to its MEAI treatment for binge behavior.
Read more at globenewswire.com1
-0.05 (-4.76%)
Find more stocks in the Stock Screener
CMND Latest News and Analysis
2 days ago - ChartmillWhich stocks have an unusual volume on Monday?Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.
